Skip Header

 

1 - 25 of 41 results for author:"Rahman N."Drop in Literature Citations

Customize display Download...

Page of 2 | Next »

Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations.

Tampellini D., Rahman N., Gallo E.F., Huang Z., Dumont M., Capetillo-Zarate E., Ma T., Zheng R., Lu B., Nanus D.M. et al.

J. Neurosci. 29:9704-9713(2009) · Mapped (9)

A zinc site in the C-terminal domain of RAG1 is essential for DNA cleavage activity.

Gwyn L.M., Peak M.M., De P., Rahman N.S., Rodgers K.K.

J. Mol. Biol. 390:863-878(2009) · Mapped (12)

A genome-wide association study of testicular germ cell tumor.

Rapley E.A., Turnbull C., Al Olama A.A., Dermitzakis E.T., Linger R., Huddart R.A., Renwick A., Hughes D., Hines S., Seal S. et al.

Nat. Genet. 41:807-810(2009) · Mapped (1)

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.

GENICA Consortium

Nat. Genet. 41:585-590(2009) · Mapped (14)

GATA-4 regulates Bcl-2 expression in ovarian granulosa cell tumors.

Kyronlahti A., Ramo M., Tamminen M., Unkila-Kallio L., Butzow R., Leminen A., Nemer M., Rahman N., Huhtaniemi I., Heikinheimo M. et al.

Endocrinology 149:5635-5642(2008) · Mapped (11)

Functional characterization of the atopy-associated gene PHF11.

Clarke E., Rahman N., Page N., Rolph M.S., Stewart G.J., Jones G.J.

J. Allergy Clin. Immunol. 121:1148-1154(2008) · UniProtKB (2) · Mapped (3)

Molecular cloning, characterisation and ligand-bound structure of an azoreductase from Pseudomonas aeruginosa.

Wang C.J., Hagemeier C., Rahman N., Lowe E., Noble M., Coughtrie M., Sim E., Westwood I.

J. Mol. Biol. 373:1213-1228(2007) · Mapped (1)

Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth.

Douglas J., Cilliers D., Coleman K., Tatton-Brown K., Barker K., Bernhard B., Burn J., Huson S., Josifova D., Lacombe D. et al.

Nat. Genet. 39:963-965(2007) · UniProtKB (1) · Mapped (3)

Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations.

Scott R.H., Homfray T., Huxter N.L., Mitton S.G., Nash R., Potter M.N., Lancaster D., Rahman N.

J. Med. Genet. 44:e83-e83(2007) · Mapped (13)

Genome-wide association study identifies novel breast cancer susceptibility loci.

Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D., Thompson D., Ballinger D.G., Struewing J.P., Morrison J., Field H., Luben R. et al.

Nature 447:1087-1093(2007) · Mapped (25)

A common coding variant in CASP8 is associated with breast cancer risk.

The Kathleen Cunningham foundation consortium for research into familial breast cancer, Breast cancer association consortium

Nat. Genet. 39:352-358(2007) · UniProtKB (1) · Mapped (77)

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.

Reid S., Schindler D., Hanenberg H., Barker K., Hanks S., Kalb R., Neveling K., Kelly P., Seal S., Freund M. et al.

Nat. Genet. 39:162-164(2007) · Mapped (2)

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

Rahman N., Seal S., Thompson D., Kelly P., Renwick A., Elliott A., Reid S., Spanova K., Barfoot R., Chagtai T. et al.

Nat. Genet. 39:165-167(2007) · Mapped (2)

A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers.

Thompson D., Seal S., Schutte M., McGuffog L., Barfoot R., Renwick A., Eeles R., Sodha N., Houlston R., Shanley S. et al.

Cancer Epidemiol. Biomarkers Prev. 15:2542-2545(2006) · Mapped (4)

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.

Seal S., Thompson D., Renwick A., Elliott A., Kelly P., Barfoot R., Chagtai T., Jayatilake H., Ahmed M., Spanova K. et al.

Nat. Genet. 38:1239-1241(2006) · Mapped (1)

ATM and breast cancer susceptibility.

Ahmed M., Rahman N.

Oncogene 25:5906-5911(2006) · Mapped (8)

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.

Renwick A., Thompson D., Seal S., Kelly P., Chagtai T., Ahmed M., North B., Jayatilake H., Barfoot R., Spanova K. et al.

Nat. Genet. 38:873-875(2006) · Mapped (8)

Steroid receptor coactivator-3 is required for progesterone receptor trans-activation of target genes in response to gonadotropin-releasing hormone treatment of pituitary cells.

An B.S., Selva D.M., Hammond G.L., Rivero-Muller A., Rahman N., Leung P.C.

J. Biol. Chem. 281:20817-20824(2006) · Mapped (16)

PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations.

McConville C., Reid S., Baskcomb L., Douglas J., Rahman N.

Am. J. Med. Genet. A 140:1297-1301(2006) · UniProtKB (1)

Evaluation of RAD50 in familial breast cancer predisposition.

Tommiska J., Seal S., Renwick A., Barfoot R., Baskcomb L., Jayatilake H., Bartkova J., Tallila J., Kaare M., Tamminen A. et al.

Int. J. Cancer 118:2911-2916(2006) · Mapped (4)

Beta-adrenergic receptor trafficking by exercise in rat adipocytes: roles of G-protein-coupled receptor kinase-2, beta-arrestin-2, and the ubiquitin-proteasome pathway.

Ogasawara J., Sanpei M., Rahman N., Sakurai T., Kizaki T., Hitomi Y., Ohno H., Izawa T.

FASEB J. 20:350-352(2006) · Mapped (3)

Molecular cloning and spatiotemporal expression of prostaglandin F synthase and microsomal prostaglandin E synthase-1 in porcine endometrium.

Waclawik A., Rivero-Muller A., Blitek A., Kaczmarek M.M., Brokken L.J., Watanabe K., Rahman N.A., Ziecik A.J.

Endocrinology 147:210-221(2006) · UniProtKB (2)

Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations.

Tatton-Brown K., Douglas J., Coleman K., Baujat G., Cole T.R., Das S., Horn D., Hughes H.E., Temple I.K., Faravelli F. et al.

Am. J. Hum. Genet. 77:193-204(2005) · Mapped (10)

Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.

Little S.E., Hanks S.P., King-Underwood L., Jones C., Rapley E.A., Rahman N., Pritchard-Jones K.

J. Clin. Oncol. 22:4140-4146(2004) · Mapped (7)

Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B.

Hanks S., Coleman K., Reid S., Plaja A., Firth H., Fitzpatrick D., Kidd A., Mehes K., Nash R., Robin N. et al.

Nat. Genet. 36:1159-1161(2004) · UniProtKB (1)

Page of 2 | Next »